TNFSF10 and cancer: To overcome this resistance, researchers are exploring the use of various approaches, including combining chemicals or natural products with recombinant TRAIL or specific monoclonal antibodies targeting TRAIL receptors, although the synergistic cancer cell killing mechanism of these combinations remains unclear.